|
CNDO-109-activated allogeneic natural killer cells |
|---|---|
| Trade Name | |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2012-06-18 00:00:00 |
| Sponsor | Fortress Biotech, Inc.;2 Gansevoort Street, 9th Floor;New York, New York, 10014 |
